A24 IPF: CLINICAL STUDIES, THERAPEUTICS, AND MORE I: Differences In Patient And Physician Viewpoints Of The Management Of Idiopathic Pulmonary Fibrosis (ipf)

A24 IPF: CLINICAL STUDIES, THERAPEUTICS, AND MORE I: Differences In Patient And Physician Viewpoints Of The Management Of Idiopathic Pulmonary Fibrosis (ipf)

Furthermore, survey results suggest that PP may be more confident with the benefit-risk profile of antifibrotic treatment than WWP. A belief in effective treatment options may ease the difficult conversation with patients regarding the seriousness of a confirmed IPF diagnosis, thereby enabling patie...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:American journal of respiratory and critical care medicine 2017-01, Vol.195
Hauptverfasser: Maher, T M, Swigris, J J, Kreuter, M, Wijsenbeek, M, Axmann, J, Ireland, L, Nathan, S D
Format: Artikel
Sprache:eng
Schlagworte:
Physicians
Pulmonary fibrosis
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Furthermore, survey results suggest that PP may be more confident with the benefit-risk profile of antifibrotic treatment than WWP. A belief in effective treatment options may ease the difficult conversation with patients regarding the seriousness of a confirmed IPF diagnosis, thereby enabling patients to make informed treatment decisions.
ISSN:1073-449X
1535-4970